XML 57 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2015
INCOME TAXES [Abstract]  
Expiration of consolidated operating loss carryforwards and research credit carryforwards
The following are the consolidated operating loss carryforwards and research credit carryforwards that will begin expiring as follows:

Calendar Years
 
Consolidated Operating Loss Carryforwards
  
Research Activities
 Carryforwards
 
  2021
 $34,248  $--- 
  2023
  95,666   --- 
  2024
  910,800   13,584 
  2025
  1,687,528   21,563 
  2026
  11,950,281   60,797 
  2027
  3,431,365   85,052 
  2028
  8,824,940   139,753 
  2029
  6,889,761   81,940 
  2030
  5,113,583   41,096 
  2031
  3,728,626   43,592 
  2032
  3,695,792   8,690 
  2033
  3,187,559   15,882 
  2034
  1,797,031   19,491 
  2035
  2,594,151   21,113 
  Total
 $53,941,331  $552,553 
Deferred tax assets and deferred tax liabilities
An analysis of the tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at December 31, 2015 and 2014 are as follows:

   
2015
  
2014
 
Deferred tax assets:
      
Net operating loss carryforwards
 $19,179,724  $18,279,724 
Intangible assets
  132,836   188,944 
Other
  605,231   554,404 
Total gross deferred tax assets
  19,917,791   19,023,072 
          
Deferred tax liabilities:
        
Property and equipment
  12,541   33,696 
Total gross deferred tax liabilities
  12,541   33,696 
          
Net total of deferred assets and liabilities
  19,905,250   18,989,376 
Valuation allowance
  (19,905,250)  (18,989,376)
Net deferred tax assets
 $---  $--- 
Reconciliation of expected statutory federal income tax rate to actual income tax rate
The following is a reconciliation of the expected statutory federal income tax rate to our actual income tax rate for the years ended December 31:

   
2015
  
2014
 
Expected income tax (benefit) at federal statutory tax rate -35%
 $( 961,543) $( 681,109)
          
Permanent differences
  53,653   52,273 
Research tax credits
  (21,113)  (19,491)
Amortization of deferred start up costs
  ---   --- 
Valuation allowance
  929,003   648,327 
Income tax expense
 $---  $---